Literature DB >> 2168146

Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp.

T Lambert1, G Gerbaud, P Bouvet, J F Vieu, P Courvalin.   

Abstract

The distribution of the aphA6 gene, encoding a 3'-aminoglycoside phosphotransferase type VI, was studied by dot blot hybridization with 115 amikacin-resistant Acinetobacter strains from various geographical areas. Nucleotide sequences related to aphA6 were found in 109 strains belonging to seven species. As inferred from results of Southern hybridization, dissemination of amikacin resistance in Acinetobacter spp. is due to a gene rather than a strain or plasmid epidemic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168146      PMCID: PMC171792          DOI: 10.1128/AAC.34.6.1244

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  beta-Lactamase and beta-lactam antibiotics resistance in acinetobacter anitratum (syn: A. calcoaceticus).

Authors:  T Morohoshi; T Saito
Journal:  J Antibiot (Tokyo)       Date:  1977-11       Impact factor: 2.649

2.  Plasmid-mediated mechanisms of resistance to aminoglycoside-aminocyclitol antibiotics and to chloramphenicol in group D streptococci.

Authors:  P M Courvalin; W V Shaw; A E Jacob
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

3.  RP4-mediated conjugation in Acinetobacter calcoaceticus.

Authors:  K J Towner; A Vivian
Journal:  J Gen Microbiol       Date:  1976-04

4.  Plasmid transfer and behaviour in Acinetobacter calcoaceticus EBF65/65.

Authors:  B A Chopade; P J Wise; K J Towner
Journal:  J Gen Microbiol       Date:  1985-10

5.  Evidence of plasmid-mediated production of aminoglycoside-modifying enzymes not previously described in Acinetobacter.

Authors:  B E Murray; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

6.  Phage-types and susceptibility to 26 antibiotics of nosocomial strains of Acinetobacter isolated in Portugal.

Authors:  M O Santos Ferreira; J F Vieu; B Klein
Journal:  J Int Med Res       Date:  1984       Impact factor: 1.671

7.  Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.

Authors:  M M Moody; C A de Jongh; S C Schimpff; G L Tillman
Journal:  JAMA       Date:  1982-09-10       Impact factor: 56.272

8.  Transferable plasmid-mediated antibiotic resistance in Acinetobacter.

Authors:  F W Goldstein; A Labigne-Roussel; G Gerbaud; C Carlier; E Collatz; P Courvalin
Journal:  Plasmid       Date:  1983-09       Impact factor: 3.466

9.  Transposon-mediated multiple antibiotic resistance in Acinetobacter strains.

Authors:  M Devaud; F H Kayser; B Bächi
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use.

Authors:  J F Levine; M J Maslow; R E Leibowitz; A A Pollock; B A Hanna; S Schaefler; M S Simberkoff; J J Rahal
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

View more
  22 in total

1.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit.

Authors:  C Arpin; L Thabet; H Yassine; A A Messadi; J Boukadida; V Dubois; L Coulange-Mayonnove; C Andre; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

3.  blaNDM-1 is a chimera likely constructed in Acinetobacter baumannii.

Authors:  M A Toleman; J Spencer; L Jones; T R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

4.  Novel plasmid and its variant harboring both a bla(NDM-1) gene and type IV secretion system in clinical isolates of Acinetobacter lwoffii.

Authors:  Hongyan Hu; Yongfei Hu; Yuanlong Pan; Hui Liang; Haiyan Wang; Xiumei Wang; Qinfang Hao; Xiaoli Yang; Xi Yang; Xue Xiao; Chunguang Luan; Yi Yang; Yujun Cui; Ruifu Yang; George F Gao; Yajun Song; Baoli Zhu
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

5.  Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid.

Authors:  J D Hopkins; A Flores; M del Pilar Pla; S Lester; T F O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 6.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

7.  Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.

Authors:  J Vila; J Ruiz; M Navia; B Becerril; I Garcia; S Perea; I Lopez-Hernandez; I Alamo; F Ballester; A M Planes; J Martinez-Beltran; T J de Anta
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 8.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

9.  Detection of aac(6')-I genes in amikacin-resistant Acinetobacter spp. by PCR.

Authors:  M C Ploy; H Giamarellou; P Bourlioux; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 10.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.